Testing a new hormone-blocking medication for Cushing's syndrome

This trial is testing a new medication called atumelnant in adults with Cushing's syndrome—a serious condition where the body produces too much of a hormone called cortisol. The medication works by blocking ACTH, a hormone that triggers cortisol production. Researchers want to understand whether the treatment is safe and how it affects cortisol levels in the body.

Cushing's syndrome can cause serious health problems, and current treatments don't work for everyone or may have side effects. This medication represents a new approach to controlling the condition by targeting the root cause—the signal that tells your body to make too much cortisol.